RCKT

Rocket Pharmaceuticals Inc (RCKT)

US
$ 8.87.22%

Price Chart

Key Statistics

Market Cap
$ 340.45M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
2.46M
52W High
$ 26.98
52W Low
$ 2.19
Dividend Yield
0.00%
Beta
0.68

Technicals

50-Day MA
4.277
200-Day MA
10.0238
52 Week High
26.98
52 Week Low
2.19

About RCKT

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the United S.

Employees
299
Headquarters
Cranbury, NJ
CEO
Dr. Gaurav D. Shah M.D.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
JELD
JELD-WEN Holding In...
$ 4.40
12.24
LVS
Las Vegas Sands Cor...
$ 47.36
8.87
CCS
Century Communities...
$ 61.22
8.70
KTB
Kontoor Brands Inc....
$ 71.65
8.61
BBWI
Bath & Body Works I...
$ 32.40
8.14

Top Losers

Symbol/Name
LTP
% Chg
ACHR
Archer Aviation Inc...
$ 9.97
-8.11
AMC
AMC Entertainment H...
$ 2.87
-7.42
OKLO
Oklo Inc.
$ 52.29
-6.58
QS
QuantumScape Corpor...
$ 6.29
-6.40
SE
Sea Limited America...
$ 150.49
-5.96